Viewing Study NCT01923168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2026-02-04 @ 10:39 AM
Study NCT ID: NCT01923168
Status: COMPLETED
Last Update Posted: 2018-09-14
First Post: 2013-08-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BYL719 View
None alpelisib View
None Breast Cancer View
None BKM120 View
None buparlisib View
None Pathological Complete Response View
None neoadjuvant View
None hormone receptor-positive View
None HER2 negative View
None Objective Response Rate View